Oncology

Latest News

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com

COA 2025: Insight, Innovation, and Independent Strength

By Maggie L. Shaw

May 5th 2025

The 2025 Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for enhancing community cancer care.

Community Oncology Reacts to Trump's Drug Pricing Executive Order

By Maggie L. Shaw

May 2nd 2025

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com

5 Things You Should Know About Skin Cancer

By Pearl Steinzor

May 2nd 2025

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com

Patient Navigation Is Nonnegotiable in Cancer Care

By Maggie L. Shaw

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg

Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

By AJMC Contributor

May 1st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

August 18th 2014

Editorial: Can Gene Signatures Tell Us All?

The writer asks: is more information better, even if we don't understand what it means?

August 18th 2014

BRCA2 Mutation: Poor Prognosis in Prostate Cancer

The study, published in the British Journal of Cancer, observed poor survival at the end of the follow-up period in men carrying the mutation, compared to non-carriers.

August 18th 2014

Model Evaluates Efficient Use of the PSA Test

The analysis recommends conducting the PSA test in those less than 70 years of age, to avoid overdiagnosis while reducing death by at least 50%.

August 17th 2014

American Cancer Society Releases Guide for Prostate Cancer Survivor Management

August 16th 2014

Two Leading Cancer Organizations, ASCO and AACR, Take a Stand on E-Cigarettes

ASCO and AACR want to see stricter regulation of the products, touching various aspects such as flavors, child-proofing, refills etc.

August 15th 2014

Medicare Proposes Covering Newly Approved Cologuard Test for CRC Detection

The final decision on the proposal will be made only after a 30-day comment period.

August 15th 2014

"Value" Decision by NICE Met With Disapproval

Both, the scientific community and a charitable organization, Prostate Cancer UK, have criticized the drug approval body for not offering abiraterone to sufferers until after chemotherapy.

August 14th 2014

Fifteen-Year Study Identifies BMI as a Risk Factor for Ten Cancers

The study, published in Lancet, reaffirms that being obese and overweight can be a major health burden and can lead to various other diseases.

August 14th 2014

Amgen's Kyprolis Fails in Phase 3 MM Trial

Kyprolis failed to improve survival in the phase 3 FOCUS trial in patients who had relapse following at least 3 prior regimens.

August 13th 2014

Blood Test Could Detect DNA from Cancerous Cells: A Liquid Biopsy

Scientists at Hopkins are working on developing a test that can rapidly sequence cellular DNA in a blood sample for early diagnosis of cancer, which could have a tremendous potential in asymptomatic subtypes of the disease.

August 13th 2014

CMS Working on a New Oncology Payment Model

CMS provided COA a draft of an episode-based payment model being developed at their Innovation Center. COA has been in collaboration with CMS on developing this model.

August 13th 2014

Lin28b Identified As a Key Gene Responsible for Childhood Cancers

The gene, normally expressed only in a developing embryo, was found expressed in several different childhood cancers.

August 13th 2014

Wikipedia-The Next WebMD?

With the aim to authenticate and regulate medical information, Cancer Research UK plans to provide the most up-to-date and accurate healthcare information.

August 12th 2014

Cologuard Receives FDA Nod for CRC Diagnosis

Cologuard had received recommendation for premarket approval from a FDA advisory panel back in March.

August 12th 2014

Poor Cancer Outcomes Among the Uninsured and those on Medicaid

The study, published in the Journal of Clinical Oncology, examined national statistics for the period between 2007 to 2010 for people aged 18-64 of age.

August 12th 2014

Kaiser Permanente Study Confirms Efficacy of Shingles Vaccine Post-Chemotherapy

August 11th 2014

Targeting the HPV Genome To Prevent Cervical Cancer Progression

Using the genome editing tool known as CRISPR, researchers were able to selectively silence two genes in HPV that are responsible for the growth and survival of cervical carcinoma cells.

August 11th 2014

Velcade Approved by the FDA for Retreatment of MM patients

The approval follows results from the RETRIEVE trial, conducted in patients who had previously responded to Velcade but had relapsed.

August 11th 2014

Encouraging Findings on Lung Cancer Rates in the US

Although the overall rate of NSCLC is lower, certain subtypes of the disease fared better than others, the study published in the journal Cancer found.

August 11th 2014

PALB2 Gene May Increase Women's Risk of Breast Cancer

Katie Sullivan, MA

New research found that the risk of developing breast cancer increased in women who had mutations of a gene related to BRCA2, the PALB2 gene.

August 8th 2014

Genetic Make-up, Not Tissue of Origin, Should Dictate Cancer Treatment: New Study

The research, published in the journal Cell, proposes revising treatment based on the molecular constitution of the tumor when it presents itself, rather than the tissue or organ of origin.

August 8th 2014

The Value Discussion in Cancer Care Escalates: NICE and Roche

According to Sir Andrew Dillon, chief executive of NICE, the high price that Roche is demanding for Kadcyla is beyond the means of NHS to cover.

August 7th 2014

Mutation in a BRCA2-Related Gene: Increased Risk of Breast Cancer

The study, published in NEJM, proposes enhanced surveillance in women with PALB2 mutations, similar to women harboring BRCA2 mutations.

August 7th 2014

Hospice Discharges in the South Raise Questions

High rate of hospice survivors, especially in Alabama and Mississippi, have raised doubts about improper practices.

August 7th 2014

Novel ER Gene Fusion Identified in Luminal B Breast Cancer

Published in Nature Communications, the study identified a new gene fusion and rearrangement of the estrogen receptor, responsible for the aggressive nature of luminal B breast cancer.

August 7th 2014

The PSA Debate Continues

The Lancet study, conducted in Europe, found a survival benefit with early diagnosis, but does not agree that the benefit outweighs some of the associated risks of the test.

August 5th 2014

FDA Accepts sNDA for Incyte's Jakafi

The results of ruxolitinib's RESPONSE trial were recently presented at ASCO's annual meeting.

Amy Berman, BS, RN, On the Benefits of the Triple Aim in Oncology Treatment

August 5th 2014

Amy Berman, BS, RN, On the Benefits of the Triple Aim in Oncology Treatment

Amy Berman, BS, RN, senior program officer at the John A. Hartford Foundation, says that the triple aim promotes better health, better care, and lower costs. All too often, however, current oncology treatment regimens do not achieve the triple aim.

August 5th 2014

Senators Enquire on Policy for Biosimilars

Within a week of Sandoz applying for approval of it's biosimlar to Amgen's Neupogen, U.S. senators want the FDA to lay down guidelines on naming these drugs.

August 4th 2014

Amgen's ASPIRE Trial Meets Primary Endpoint in Phase 3 for MM

The study evaluated carfilzomib in combination with Celgene's lenalidomide and dexamethasone.

...

154 155 156 157 158 159 160 161 162

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions